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Abstract 
Aim 
The aim of this study was to describe the prevalence and outcomes of a cohort of children with cerebral 
palsy and upper airways obstruction admitted over a five year period to a single institution in Cape Town, 
South Africa.  
Methods 
A retrospective cohort study was conducted of all children between the ages of 2 and 18 years admitted with 
cerebral palsy during the study period.  Information about the classification and severity of cerebral palsy, 
investigation and management of upper airways obstruction and patient outcomes were collected.  
Results 
Three hundred and thirty children with cerebral palsy were admitted over the five year period. The 
prevalence of UAO in the cohort during the study period was 8.8% (n=29).The median age on admission of 
children with UAO was four years. (IQR: 2, 6)  
Six (20.7%) children with upper airways obstruction died during the study period as compared to 30 (9%) 
children without upper airways obstruction. Feeding complications and severe physical disability were found 
to be associated with upper airways obstruction (p=0.0000) as well as study mortality (p=0.0004) 
Significance 
This report highlights the contribution of UAO to respiratory compromise in children with cerebral palsy.  
Word count: 191 
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What this paper adds 
The prevalence of upper airways obstruction in a cohort of hospitalised children from Africa with cerebral 
palsy is 8.8%. 
Children from our cohort present at a younger age compared to other reports. 
Feeding complications and severe physical disability are associated with UAO in this cohort of children with 
CP. 
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Background and significance 
Cerebral palsy (CP) has been defined as a “group of disorders of the development of movement and 
posture, causing activity limitation that is attributed to non-progressive disturbances that occurred in the 
developing foetal or infant brain. The motor disorders are often accompanied by disturbances of sensation, 
perception, cognition, communication, and behaviour; by epilepsy, and by secondary musculoskeletal 
problems.” 
1  
While the prevalence of CP has been reported to be around 2-2.2/1000 live births in developed 
countries, it is estimated that this may be as high as 10/1000 in Africa.
2 
Respiratory complications are 
reported to be significant contributors to morbidity and mortality in children with cerebral palsy and other 
developmental disabilities.
3
 
Children with CP are at increased risk for obstructive sleep apnoea and upper airways obstruction (UAO).
3-6 
This is thought to be the result of mid-facial and gastro intestinal abnormalities as well as the underlying low 
neuromuscular tone of the upper airway which predisposes to upper airway compromise. 
3, 7
 Additional 
potential contributors to UAO during sleep in children with CP are tonsillar and adenoidal hypertrophy, 
subglottic stenosis, laryngomalacia, tracheomalacia, and obesity.
4  
Common symptoms of upper airways obstruction include snoring, noisy breathing, stridor and obstructive 
sleep apnoea. These are believed to be underreported by parents, particularly in children with other 
significant medical conditions such as CP. 
8 
Children may also present with complications of chronic UAO 
including pulmonary hypertension and cardiac failure.  
The acute management of severe UAO may necessitate admission to an intensive care unit while chronic 
UAO may result in long term respiratory insufficiency, secondary cardiac complications and mortality. 
Chronic UAO is an important contributor to poor quality of life in both neurotypical as well as children with 
developmental disabilities such as CP.
6
 
The management of UAO in children with CP is complex due to the multifactorial nature of the aetiologies. 
Adenotonsillectomy is generally recommended as an appropriate first-line intervention.
7
 When severe 
airways obstruction persists following adenoidectomy and tonsillectomy, more invasive surgical procedures 
may be attempted, for example uvulopalatopharyngoplasty, maxillofacial procedures or tracheostomy, for 
definitive airway management.
9-11 
Non-invasive management in the form of continuous nasal positive 
pressure or home oxygen have also been utilized to administer respiratory support where a decision has 
been made that surgical intervention is not appropriate.
7
 
There is a paucity of data to guide current best practice in the management of children with CP and severe 
UAO. The available publications present reviews of practices in first world settings and report mainly on 
small groups, often mixed with other disabilities. These studies are not able to report on health or quality of 
life outcomes for children with CP. The author could find no reports about the prevalence, severity and 
management of UAO in children with CP from developing countries or resource limited settings. 
The aim of the study was to report the prevalence of UAO in a cohort of children with CP admitted to a South 
African hospital over a five year period. Furthermore, we aimed to describe the characteristics of this group 
and to explore possible associations between the nature and severity of CP, their comorbidities and 
outcomes of the children during the study period. 
Methods 
A retrospective cohort study was conducted of all children with CP admitted to Red Cross War Memorial 
Children’s Hospital (RWMCH), Cape Town, South Africa, during the study period of January 2009 to 
December 2013. Red Cross War Memorial Children‘s Hospital is one of two tertiary institutions in the Cape 
Town metropole and is a designated referral hospital for children with neuro-disabilities from the metro west 
area, which includes a paediatric population in excess of 500,000. 
12 
Outcome data was collected until 
December 2014 to allow for at least one year follow up for children who were admitted in 2013.  
Participants 
All children with a diagnosis of CP between the ages of 2 and 18 years who were admitted to any ward at 
RWMCH and who were documented to have a diagnosis of UAO between 1 January 2009 and 31 December 
2013 were included in the study. Children with known craniofacial disorders including craniosynostosis or 
cleft palate were excluded. Children for inclusion were identified from the hospital admission data based on 
ICD 10 codes for cerebral palsy. Data collection was performed by the principal investigator who is a 
developmental paediatrician.  
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Demographic and clinical information were collected on all patients with CP during the study period. Data 
included the aetiology of CP, classification of CP, as well as the presentation, investigation and management 
of UAO and mortality during the study period. Nutritional assessment was performed by plotting admission 
weight for age using the Life Expectancy Project growth charts for children with cerebral palsy. 
13 
Statistical analysis 
Statistical analysis was performed using the STATA 13 programme
14 
using continuous and categorical 
variables. 
 
Categorical variables were reported as percentages. Numerical variables, which were not normally 
distributed, were reported as median with interquartile range. Study mortality was reported as a relative 
percentage. Comparison between groups was performed using the Fischer’s exact test. A p value < 0.05 
was considered significant. 
A multivariable logistic regression analysis for the outcome mortality was carried out. The factors studied 
were entered into the model as independent variables provided they were associated in the univariate 
analysis (with p < 0.05). Forward stepwise procedures were used to construct the model (significance level 
for entry or removal was 5%). Multivariable logistic regression analysis was also performed to determine 
possible predictors for UAO in the cohort. 
Ethical considerations 
Ethical approval was obtained from University of Cape Town, Human Research Ethics Committee prior to 
commencement of any study activities. HREC/REF: 916/2014 
As the study was retrospective in nature and involved no risks to patients, permission was obtained from the 
Human Research Ethics Committee to waive individual signed consent. Patient data was anonymised to 
ensure confidentiality. 
Results 
A total of 330 children with cerebral palsy were admitted during the study period.  There was a male 
predominance amongst the children admitted (n=187, 56.7%). In keeping with other reports from sub-
Saharan Africa, the most common reported aetiology for cerebral palsy in the cohort were complications in 
the perinatal period (n= 177, 53.6%).
15, 16
 The majority of children had severe spastic cerebral palsy (Spastic 
CP = 86.7% and Gross Motor Functional Classification [GMFCS] scale IV and V= 69%) (Table I). 
Children with upper airways obstruction  
Twenty nine of the children with cerebral palsy were documented to have signs and symptoms of upper 
airways obstruction as admission diagnosis or major contributing factor to admission (prevalence of 
UAO=8.8 %). Children with UAO appeared to have more significant physical disability compared to the 
overall cohort (96% were classified as GMFCS IV and V as compared to 66% [p=0.01] of the overall cohort) 
and presented with a higher frequency of documented feeding complications compared to children without 
UAO (p=0.002) (Table I). Feeding complications reported in the cohort included gastro oesophageal reflux, 
silent aspiration as well as incoordinate swallowing. 
The median age of children admitted with CP and UAO was four years (IQR: 2- 15years). The median 
duration of admission was eight days (IQR: 1-50 days). The median admission weight was 10 kg. (IQR:6.8-
30kg). Twenty-one children (72%) with UAO were assessed to have normal nutritional status. Seven children 
(24%) were classified as underweight for age and only one child (3%) was classified as overweight.  
Upper airways obstruction: investigation and management  
The most common presenting symptoms on history included snoring in 14 children (48.3%) and noisy 
breathing in six children (20.6%). There were no parental or caregiver report of awake obstructive apnoea 
but nine children (31%) presented with a history of obstructive sleep apnoea (Table II). Fourteen children 
(48%) were known to the institution with chronic upper airways obstruction prior to hospital admission of 
which seven (50%) had been investigated previously in the form of nasal endoscopy and seven (50%) had 
been managed by adenoidectomy or tonsillectomy. 
A limited number of investigations were done to determine the cause and severity of UAO in the cohort. Two 
children (6.9%) had radiographs of the posterior nasal space on admission, which confirmed adenoidal 
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hypertrophy in both cases. Three children (10.3%) had electrocardiograms reported as normal, and eight 
children (27.6%) were assessed by overnight sleep oximetry. Severe sleep apnoea was confirmed in three 
children (37.5%) on sleep oximetry. Fourteen children (48%) had nasal endoscopy done during admission. 
Findings on endoscopy included adenotonsillar hypertrophy in five children (35.7%), reflux related changes 
in two children (14%), vocal cord paralysis in two children (14%) and multifactorial changes in three children 
(21%). In two children (14%), endoscopy findings were reported as normal. Twenty-two children (75%) were 
reviewed by an otolaryngologist during the admission. None of the children in the study were assessed with 
formal polysomnography as this was not available at our institution during the study period. 
The final cause of UAO was ascribed to multifactorial contributors in 19 children (65.5%). Adenoidal or 
tonsillar hypertrophy was considered to be a contributing factor to UAO in only five children (17%). Other 
causes of UAO reported in the cohort included one child (3.4%) with vocal cord paralysis, one (3.4%) with 
laryngo-tracheobronchitis and one (3.4%) with laryngomalacia. The multivariate logistic regression analysis 
model found feeding complications and severe physical disability to be associated with UAO (Table IV). In 11 
children (37.9%), the UAO was managed by continuous insufflation of the pharynx (CIP) (Table III). The 
mean (SD) duration of CIP placement was four days (IQR=2- 8 days). In contrast only three children (10.3%) 
were managed by continuous nasal positive airway pressure and four children (13.8%) required mechanical 
ventilation. Six children (20.9%) were admitted to the intensive care unit with median admission duration of 
3.5 days (IQR: 2-4 days). In 18 cases (66.6%), a decision was made in discussion with families to offer 
supportive medical treatment only. Placement of a surgical airway in the form of a tracheostomy tube was 
performed on four children (13.8%) during first admission for UAO. In total, nine (31%) children were 
managed with tracheostomy tube placement during the study period. 
Thirty-six children with CP died during the study period, of which six were children with UAO. Mortality during 
the study period for children with UAO was 20.7%.  Severe physical disability and feeding complications 
were found to be associated with mortality in the multivariate regression analysis model. Three children had 
tracheostomies in situ when they died. Mortality data from medical records could not confirm final cause of 
death in these children as the majority of children (n=4, 66.6%) died at home. The median age at death was 
seven years and five months. The range was from three years and five months to 14 years and six months. 
Twelve children (41%) with UAO were readmitted to hospital in the year following their first admission for 
continuing UAO complaints. Three of these children required readmission to the intensive care unit. 
(Children who were managed conservatively were more likely to be readmitted with upper airways 
complaints (p=0.008).  
Discussion 
Our study reports a high prevalence of UAO amongst a cohort of hospitalised children with CP in Cape 
Town, South Africa as well as a high mortality rate for this group. This is the first study to document the 
prevalence and outcomes of UAO in hospitalised children with CP in Africa. The inclusion of all children with 
CP admitted over the study period presents supportive information as to potential contributory factors to 
UAO in children with cerebral palsy in this resource limited setting. 
 
Many of the children in our cohort had a history of chronic symptoms of UAO and yet limited investigations 
had been done to evaluate the cause or severity of the UAO prior to study admission. A study by Wilkinson 
et al.
17
 in Australia reported a similar lack of investigations in their cohort. Most of the children in this study 
were reported to have had gradual onset of symptoms but with limited investigations to assess aetiology or 
severity. 
 
A study by Shintani et al. in 1997
18
 investigated UAO in an outpatient based cohort of Japanese children with 
CP by means of a survey and reported symptoms of chronic UAO in 20% of a cohort of 223 children. The 
study did not report outcomes of the children or investigations that had been performed but did report 
pharyngeal collapse as the most frequent cause of UAO. 
18 
Our findings support concerns that the 
prevalence and severity of UAO in children with CP may be underestimated by parents and in routine clinical 
practice. 
8, 17
 
In twenty four percent of our cohort the initial surgical management of UAO was adenotonsillectomy. 
However, nine children (31 %) required formal airway management in the form of tracheostomy tube 
placement. The tracheostomy home care program was pioneered at our institution in 1989 and has enabled 
children with surgical airways to be cared for safely at home in a resource limited setting where the cost of 
home oxygen or provision of positive pressure airways support devices is not feasible .
19
 In a recent study 
conducted over 6 years, Kontorinis et al. 
7
 from the United Kingdom investigated the progression of UAO in 
15 children with CP admitted to their unit. In this cohort children presented at a mean age of eight years and 
tracheostomy placement was performed in 53% of the cohort at mean age of 11.6 years. They concluded 
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that UAO in children with CP progressed with age, and postulated that deterioration in oropharyngeal tone 
was a major contributor to progression of UAO.
 
 
In contrast, children in our study presented at a much younger age (median age of four years) and had a 
lower rate of adenotonsillectomy (24% vs 63.6%) as well as tracheostomy placement (31% vs 53%). The 
lower rate of tracheostomy tube placement might be accounted for by the younger age of our cohort. It is 
possible that children in the South African context present at a younger age with severe UAO because of the 
increased severity of CP in our setting.  
The high prevalence of respiratory infections as a cause of hospital admission in developing countries could 
also have a role as contributing factor to the burden of disease in this cohort. 
20
 In addition the large number 
of cases (62%) where a decision was made in favour of conservative management as opposed to 
tracheostomy placement may account for the lower proportion of tracheostomy placements in our study.  
Risk factors for UAO in children with CP identified from our regression analysis include feeding complications 
and severe disability. (GMFCS IV and V) The unusual finding of reduced risk for UAO in children with 
epilepsy in this cohort could be explained by possible biased admission of children with poorly controlled 
seizures to our institution as the referral centre for both epilepsy and cerebral palsy.  
These findings have potential implications for clinical management by suggesting subgroups of children who 
are at high risk of UAO. This could support clinical recommendations for routine review of UAO symptoms at 
follow up visits as well as screening for obstructive sleep apnoea in children in GMFCS IV and V, particularly 
those with comorbidities of epilepsy and feeding complications. Recommendations from the research 
presented by Kontorinis et al. 
7
 included suggestions that UAO should also be considered in children as they 
enter adolescence and screening and management of upper airway symptoms should be included in care 
plans for adolescents and adults with CP. 
Severe physical disability (GMFCS IV and V) and feeding complications were found to be associated with 
mortality in this cohort from Africa. This finding is in keeping with international data and emphasizes the high 
risk for mortality in our local setting. 
21
 Cohorts from Africa have reported a higher frequency of children with 
severe physical disability compared to other settings which may place our children at increased risk for poor 
quality of life and early mortality. 
16, 22 
In resource limited settings, access to subspecialist services, surgical airway management or non-invasive 
airway support is limited. The appropriate management of children with CP, severe physical disability and 
UAO presents a challenge. Furthermore adult services for patients with CP are not well developed in South 
Africa and the growing number of adolescents with surgical airways remains without any designated adult 
service providers to take over their care. The effect on family quality of life and economic consequences of 
current management strategies remain to be seen. 
Limitations 
The study is limited by its retrospective design and small study number. The study was conducted in a 
tertiary hospital in a resource constrained setting in Africa. Our results may reflect outcomes in a more 
severe cohort with cerebral palsy and hence may not be generalizable to children with cerebral palsy in other 
settings. As the study reports children admitted to hospital, study findings may also not accurately reflect the 
burden of UAO for the population of children with CP in Cape Town. Children with severe UAO may have 
died before reaching hospital and milder cases in the community may remain undiagnosed. 
Conclusion  
This study highlights the contribution of UAO to respiratory compromise and mortality in children with 
cerebral palsy. Symptoms of UAO may be missed by parents or caregivers and disease severity maybe be 
underestimated by clinicians. Investigation and management of UAO requires resources in the form of 
access to subspecialist services and multidisciplinary team support. This is challenging in resource limited 
settings particularly in the absence of clear clinical guidelines. Tracheostomy tube placement is used as 
definitive airway management both internationally and locally. However, information about outcomes in 
accordance with International Classification of Functioning, Disability and Health core sets, especially with 
regards to quality of life of affected children and caregivers, is lacking internationally and locally. Further 
research into this important clinical problem is indicated. 
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Table I: Descriptive statistics of children with CP   
 Children with 
CP* 
Without UAO 
n=301 (%) 
Children with 
CP   
and UAO 
n=29 (%) 
Odds Ratio 
with 
95% CI 
p value 
Sex           
  
0.9 
(0.4-2) 
0.82 
Male 170 (56.6) 18 (58.6)   
Aetiology     
Antenatal 17(5.7) 2(6.9)   
Perinatal 162(53.8) 15(51.7)   
Postnatal  69(22.9) 6(20.7)   
Unknown 37(12.2) 6(20.7)   
Incomplete data 16(5.3)    
Distribution 
  
0.3 
(0.1-1.5) 
0.159 
Bilateral 272(90.4) 29 (100)   
Unilateral 29(9.6)    
Predominant tone 
abnormality 
    
Spastic 261(86.7) 25 (86.2)   
Dystonic 16(5.3) 3 (10.3)   
Mixed  18(6) 1 (3.5)   
Hypotonic 3(1)    
GMFCS classification 
  
14 
(1.8-105) 
0.01 
I-III 61(20.2) 1(0.5)   
IV-V 200(66.5) 
 
28(96.5) 
 
 
 
 
Epilepsy 
 
221(73.4) 
 
14 (48.3) 
 
3.3 
(1.5-7.1) 
 
0.003 
Visual impairment 
89(29.6)                                     12 (41.4)
0.6 
 (0.3-1.4) 
0.25 
Hearing impairment 
16(5.3) 4 (13.8) 
0.4 
(0.1-1.2) 
0.09 
Musculoskeletal 
complications 
144(47.8) 14 (48.3) 
1.3 
(0.6-2.7) 
0.56 
Feeding complications 
125(41.5) 21 (72.4) 
3.7 
(1.6-8.6) 
0.002 
Gastrostomy tube 
96(31.9) 18 (62.1) 
0.6 
(0.4-1.2) 
0.138 
Mortality  
30 (9) 6 (20.7) 
2.4 
(0.9-6.2) 
0.085 
Of the 330 children identified during the study period from ICD 10 codes as   admissions with 
CP, 301 children (91%) had *CP without UAO and 29 children (9%) had CP with UAO 
CP, cerebral palsy; UAO, upper airway obstruction; CI, confidence interval; GMFCS, Gross 
Motor Function Classification System; NCPAP, nasal continuous positive airway pressure; 
CIP, continuous insufflation of pharynx ; IPPV, intermittent positive pressure ventilation 
Unknown, no cause after full investigation; Incomplete data, incomplete medical records 
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Table II: UAO symptoms, investigation and management 
 Children with CP and UAO 
n=29 (%) 
Symptoms of UAO  
Snore 14 (48.3) 
Stridor 9 (31.0) 
Noisy breathing  6 (20.6) 
Sleep apnoea 9 (31.0) 
Investigations for UAO  
Posterior nasal space x-ray 2 (6.8) 
Sleep oximetry 8 (27.6) 
Awake nasal endoscopy 14 (48.3) 
Respiratory support provided during admission  
NCPAP 3 (10.3) 
CIP 11 (37.9) 
IPPV 4 (13.8) 
Management  
Adenotonsillectomy 7 (24.1) 
Tracheostomy 9 (31.0) 
Supportive care 18 (62.1) 
Outcomes  
Mortality 6 (20.7) 
Readmission for UAO 12 (41.3) 
CP, cerebral palsy; UAO, upper airway obstruction; NCPAP, nasal continuous positive airway 
pressure; CIP, continuous insufflation of pharynx ; IPPV, intermittent positive pressure 
ventilation 
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Table III: Respiratory support of children with UAO 
 
n (%) 
Duration in days, median 
(IQR) 
Admission 29 (100) 7 (1-50) 
Respiratory support   
NCPAP 3 (10.3) 1 (1-3) 
CIP 11 (37.9) 4 (2-8) 
IPPV 4 (13.8) 2.5 (1.5-3) 
ICU admission 6 (20.7) 3.5 (2-4) 
UAO, upper airway obstruction; IQR, interquartile range; NCPAP, nasal continuous positive 
airway pressure; CIP, continuous insufflation of pharynx; IPPV, intermittent positive pressure 
ventilation; ICU, intensive care unit 
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Table IV: Multivariate logistic analysis for mortality and UAO in children with CP 
 Crude 
p value 
Crude 
OR 
Adjusted OR 95% CI 
Mortality 
       Feeding problems 
0.0003 3.8 2.9 1.36-6.4 
Severe physical 
disability 
(GMFCS IV and V) 
0.002 4.8 2.5 0.8-7.7 
UAO     
Feeding problems 0.01 3.7 2.7 1.1-6.8 
Severe physical 
disability 
(GMFCS IV and V) 
0.002 14.1 10.1 1.3-79.6 
Without  Epilepsy 0.003 3.3 4.4 1.9-9.9 
UAO, upper airway obstruction; CP, cerebral palsy; GMFCS, Gross Motor Function 
Classification System; p value, statistical significance; OR, odds ratio, CI, confidence interval 
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4. Selection and publication  
a) Editorial review  
b) After acceptance  
c) After publication  
5. Style points  
1. Good publication practice  
The journal follows the guidelines of the International Committee of Medical Journal Editors 
(www.icmje.org) and Wiley Blackwell's Best Practice Guidelines on Publication Ethics 
(www.wiley.com/bw/publicationethics/). In particular, please note the following points.  
a) Authorship  
Our criteria for authorship are based on the International Committee of Medical Journal Editors guidelines. 
More information can be found here: www.icmje.org  
Credit for authorship should be based on  
1. Substantial contributions to research design, or the acquisition, analysis or interpretation of data;  
2. Drafting the paper or revising it critically;  
3. Approval of the submitted and final versions.  
The corresponding author must state that all the authors have read the manuscript and agreed to its being 
submitted for publication. The covering letter should state that all individuals listed as authors meet the 
appropriate authorship criteria, that nobody who qualifies for authorship has been omitted from the list, that 
contributors and their funding sources have been properly acknowledged, and that authors and contributors 
have approved the acknowledgement of their contributions. The covering letter should include a short 
description of each author’s contribution and should state whether he or she had complete access to the 
study data that support the publication.  
Contributors who do not qualify as authors should be listed, and their contribution described, in an 
acknowledgement section at the end of the article. When authors are publishing on behalf of a group, the 
membership of the larger authorship group should be listed in an appendix, or may be shown in a separate 
display box. Up to ten authors may be included on the title page.  
b) Reporting guidelines:  
For Original Articles, Systematic Reviews and Meta-analyses, the Editors and Editorial Board require that 
authors follow the guidelines of the Equator network when reporting research methods and findings 
(www.equator-network.org/library/) and the AACPDM Guidelines where appropriate for Systematic 
Reviews of Treatment Interventions (see Summary document)  
Submissions must be accompanied by the appropriate checklist, fully completed with page numbers where 
applicable. Please select the most suitable checklist from the following and download the appropriate 
checklist:  
Systematic Reviews or Meta-analyses: PRISMA: (Click here)  
Systematic Reviews or Meta-analyses following AACPDM Guidelines: Please complete both the 
PRISMA checklist and the AACPDM checklist: (Click here)  
Randomised controlled trials: CONSORT guidelines: (Click here)  
Observational studies: STROBE guidelines: (Click here)  
Other types of study e.g. Diagnostic Accuracy: please visit the Equator website www.equator-
network.org/library/  
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For Editorials, Commentaries, Book Reviews, other types of Review (i.e. not Systematic), Case Reports, 
Letters and Clinical Insights, no checklist is required.  
c) Clinical trial registration  
If publishing the results of a clinical trial, please include the clinical trial registration number. All trials should 
be registered in a publicly accessible database. Please upload a copy of the trial protocol as a 
supplementary file.  
d) Duplicate publication  
Authors should declare that the submitted work and its essential substance have not previously been 
published and are not being considered for publication elsewhere. Manuscripts must not be submitted 
simultaneously to another journal. All suspected cases of multiple submissions or redundant publication will 
be subject to investigation.  
e) Approval and consent  
Ethical approval Authors of research articles should demonstrate that the research has been approved by a 
named research ethics committee, that the committee’s recommendations have been adhered to, and that 
written informed consent for participation and publication has been obtained.  
Please include a statement in the text of your paper to indicate that ethical approval has been given and give 
the name of the body (research ethics committee, institutional review board etc.) that approved the study.  
If the institution’s research ethics committee did not consider that their approval was needed, this should be 
stated in the text.  
Consent Please indicate in the text that patients or their carers have given informed consent to the research 
and to publication of the results.  
If recognizable photographs or verbal descriptions of an individual are used in an article, written consent 
from the appropriate person(s) for publication must be submitted to, and kept by, the author. All case reports 
and clinical photographs require consent. Names, initials, or any other means of identification should not be 
shown on any photograph. Please use the Consent Form available from the DMCN submission site (Click 
here)  
f) Funding  
All sources of funding or support should be noted in the acknowledgements section of the manuscript 
(including grants from funding bodies, sponsorship or grants from commercial organisations, and donation of 
materials). During the online submission process, you will need to clarify the involvement of any funder in 
study design, data collection and analysis, and manuscript preparation. It is mandatory that a DMCN 
Disclosure Form is completed when your paper is submitted, and your paper will not be sent for review until 
we have received your form.  
g) Disclosures  
Disclosures of interest must be made during the online submission process for authors and during the 
review process for referees. Please note that the corresponding author submitting on behalf of co-authors 
must obtain full information from each author prior to submission and complete the DMCN Disclosure Form 
which can be found on the submission site (click here). All authors and referees must provide details of 
financial interests in any company or institution that might benefit from the publication of the article. Authors 
and referees should also declare any other potential competing interests that readers or editors might 
consider relevant to the research submitted for publication. In making disclosures, please consider these 
three areas (please refer to http://www.icmje.org/ethical_4conflicts.html for further information):  
1. Financial payments to you or your institution from any sources that might benefit from publication of your 
submission, and any other relevant financial interests (e.g. employment, significant share ownership, patent 
rights, consultancy, research funding);  
2. Similar financial relationships involving your spouse or partner or your dependent children;  
3. Any personal, professional, political, institutional, religious, or other associations that a reasonable reader 
would want to know about in relation to the submitted work.  
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Please note that authors’ disclosures as submitted will be reproduced at the end of your paper when it is 
published. If no disclosure is made, the following statement will be added to your paper: “The authors have 
stated that they had no interests which might be perceived as posing a conflict or bias.”  
ALL authors must sign the DMCN Disclosure Form before their paper will be published. The form should be 
submitted to the Editorial Office with your manuscript.  
h) Misconduct  
If suspicion of misconduct is raised after publication a statement of concern may be issued. All complaints or 
concerns will be investigated. Serious cases of misconduct would result in retraction. DMCN follows the 
Wiley Blackwell retraction guidelines. More information can be found here: 
http://authorservices.wiley.com/bauthor/faqs.asp#policy.  
2. Copyright  
Authors must declare that the work submitted is their own and that copyright has not been breached in 
seeking its publication. If the manuscript includes work previously published elsewhere, it is the authors’ 
responsibility to obtain permission to use it and to indicate that such permission has been granted.  
Please note that all papers will be assessed using iThenticate® which checks written work for duplicate and 
unattributed content against a large comparison database in order to ensure work is original before 
publication.  
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive 
an email prompting them to login into Author Services; where via the Wiley Author  
Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the 
paper.  
For authors signing the copyright transfer agreement If the Online Open option is not selected the 
corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and 
conditions of the CTA can be previewed below:  
CTA Terms and Conditions: http://exchanges.wiley.com/authors/faqs---copyright-_301.html. Please do 
not complete this PDF until you are prompted to login into Author Services as described above.  
Note to Contributors on Deposit of Accepted Version  
Authors are permitted to self-archive the peer-reviewed (but not final) version of the Contribution on the 
Contributor’s personal website, in the Contributor’s company/institutional repository or archive, and in certain 
not for profit subject-based repositories such as PubMed Central as listed at the following website: 
http://olabout.wiley.com/WileyCDA/Section/id-820227.html, subject to an embargo period of 12 months for 
scientific, technical and medical (STM) journals and 24 months for social science and humanities (SSH) 
journals following publication of the final Contribution.  
There are separate arrangements with certain funding agencies governing reuse of this version as set forth 
at the following website: http://www.wiley.com/go/funderstatement.  
The Contributor may not update the accepted version or replace it with the published Contribution.  
For authors choosing Online Open  
If the Online Open option is selected the corresponding author will have a choice of the following Creative 
Commons License Open Access Agreements (OAA):  
Creative Commons Attribution Non-Commercial License OAA  
Creative Commons Attribution Non-Commercial -NoDerivs License OAA  
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs 
hosted on Wiley Author Services http://exchanges.wiley.com/authors/faqs---copyright-_301.html and 
visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.  
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If you select the Online Open option and your research is funded by certain funders [e.g. The Wellcome 
Trust and members of the Research Councils UK (RCUK) or the Austrian Science Fund (FWF)] ), you will be 
given the opportunity to publish your article under a CC-BY license supporting you in complying with Funder 
requirements. For more information on this policy and the Journal’s compliant self-archiving policy please 
visit: http://www.wiley.com/go/funderstatement.  
For RCUK, Wellcome Trust, FWF authors click on the link below to preview the terms and conditions of this 
license:  
Creative Commons Attribution License OAA  
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs 
hosted on Wiley Author Services http://exchanges.wiley.com/authors/faqs---copyright-_301.html and 
visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html  
3. Presentation and formatting of your paper 
a) Maximum length requirements 
Article type  Abstract  “What this 
paper adds”  
Text words 
(excl refs)  
References  Figures/ 
tables  
Original 
article  
Structured, 
200 words  
1 to 5 points  3000  25  4  
Systematic review  Structured, 200 words  1 to 5 points   
Other review  Unstructured, 
150 words  
1 to 2 points  3000  25  4  
Case report  Unstructured, 
150 words  
1 to 2 points  1500  15  2  
Letter to the 
Editor  
None  None  750  5  1  
Editorial, 
commentary, 
opinion  
None  None  700  5  0  
Clinical 
Insights  
None  None  200-300  2  1  
b) All papers  
General: Use single-line spacing for all parts of the submission. Include tables and figure legends in your 
main article file, after the references. Submit figures (illustrations) as separate files, as described below. 
Name all files using the surname of the first author (e.g. Smith.doc, Smith fig1.tif, etc.).  
Title page Include the title of the paper, authors’ names, main appointments and primary affiliations (i.e. one 
affiliation only per author), and word count. Identify the corresponding author and give his or her postal 
address, fax number, and e-mail address.  
Abstract On the second page of original articles and systematic reviews, provide a full structured abstract of 
no more than 200 words, with the following headings: Aim; Method, Results, Interpretation. Where relevant 
the Method section should follow Equator guidelines and should include means (sd) or medians and sex for 
study and control groups, definition of clinical characteristics, entry criteria for study, assessments used, 
duration and frequency of intervention, and timing of outcome assessments. Where relevant “Results” should 
follow Equator guidelines and should summarize significant results with statistical values, including negative 
findings if related to the study hypothesis. Non-significant trends should not be noted in the abstract.  
Non-systematic reviews and case reports should have a non-structured abstract without headings of up to 
150 words, covering the aims, method, results, and conclusions of the study.  
On the abstract page, also provide a shortened form of the title (up to six words) for use as a running foot.  
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‘What this paper adds’ All original articles and systematic reviews should have a section ‘What this paper 
adds’ after the abstract. This should comprise up to five bullet points of 5-10 words each, summarizing the 
new knowledge contributed by the study. Other articles should have one or two similar bullet points.  
c) Original articles  
Articles should comprise an introductory section (but not headed ‘Introduction’), followed by ‘Method’ (with 
optional subheadings, such as ‘Participants’ [rather than ‘Subjects’] and ‘Statistical analysis’), ‘Results’, and 
‘Discussion’ sections. The Discussion section should include the limitations of the study. Subheadings 
should otherwise be kept to a minimum.  
Papers longer than 3000 words, such as those reporting randomized controlled trials, may be published at 
the Editors’ discretion.  
Randomised controlled trials should include a short trial protocol as supplementary information.  
d) Reviews  
We publish two types of review. One is a fully detailed comprehensive review of a subject, such as a 
systematic review, with full referencing and a word-count appropriate to the topic and amount of material to 
be covered. The other is intended to be a more personal view providing the reader with up-to-date 
information about the subject in question in a relatively brief format, referring to significant international 
papers but not forming a comprehensive overview of the literature. Authors are advised to refer to the paper 
by Grant et al: A Typography of Reviews published in Health Information and Libraries Journal, 2009, 
26:2, before submitting a review paper to DMCN.  
e) Case reports  
DMCN accepts case reports only if they significantly add to our understanding of a condition or present a 
novel finding. They should comprise an introductory section as above, followed by the ‘Case Report’, then a 
‘Discussion’ section.  
f) Letters to the Editor  
Letters are published at the Editors’ discretion. They may comment on a published paper, or raise issues 
that are new to DMCN. In the case of letters commenting on a published paper, normally the author of that 
paper will be invited to comment on the letter, with both letter and comments being published in the same 
issue.  
g) Clinical Insights  
Clinical images with a description of approximately 200-300 words and one or two references that fit within a 
printed page will be considered for publication in DMCN. The images can include photographs of patients, X-
rays, EEGs, and other investigations, videos, or other  material considered appropriate by the Editors. 
Images should adhere to the guidelines below (Figures). If a video is submitted please submit 2-4 illustrative 
stills that can be printed in the Journal. Please also see ‘Approval and Consent’ above.  
h) References  
The Vancouver style is used, as recommended by the International Committee of Medical Journal Editors. 
Cite using a superscript number in the text, with a numerical list of references at the end of the paper 
presented in order of citation. Cite only peer-reviewed, published material. The journal does not recognize 
abstracts or submitted (as opposed to accepted, or ‘forthcoming’) papers as proper citations; such material 
should not be listed with the references but cited only in text, followed by ‘(personal communication)’.  
List all authors unless more than six, in which case list the first three followed by ‘et al’, using Index Medicus 
abbreviations for journal names (see www.nlm.nih.gov/tsd/serials/lji.html). Order and punctuate 
bibliographic information as follows, omitting issue month and number unless needed to distinguish issues. 
For additional citation formats, adapt appropriate examples from the NLM’s Citing Medicine 
(www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=citmed).  
Abrams RA, Tsai AM, Watson B, Jamali A, Lieber RL. Skeletal muscle recovery after tenotomy and 7-day 
delayed muscle length restoration. Muscle Nerve 2003; 23: 707–14.  
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Auvin S, Joriot-Chekaf S, Cuvellier J-C, Vallée C. Familial alternating hemiplegia of childhood or 
channelopathy? [letter]. Dev Med Child Neurol 2004; 46: 500.  
Mesibov GB, Kunce L, Schopler E. Asperger syndrome or high functioning autism? Current issues in autism. 
New York: Plenum Press; 1998.  
Finnegan LP, Kaltenbach K. Neonatal abstinence syndrome. In: Hoekelman RA, Nelson NM, editors. 
Primary pediatric care. 2nd ed. St. Louis: Mosby Yearbook, Inc.; 1992. 1367–78.  
For references to online sources, supply the author names, full title, and full URL including the date on which 
the site was accessed.  
i) Figures and tables  
Note that the Editors may decide that large figures or tables should be published online-only  
Tables, figure legends and short appendices Set out on separate pages at the end of (and as part of) the 
main document, after the references.  
Tables and appendices to be published online only: Present as separate files in Microsoft Word or Rich 
Text format.  
Figures (e.g. illustrations, charts and photographs): Present electronically as separate files (not in the main 
text of the article). Guidelines about acceptable file formats and illustration preparation are provided at 
authorservices.wiley.com/bauthor/illustration.asp  
Please label radiographs, CT, or MRI scans with left [L] and right [R], and if appropriate with anterior [A] and 
posterior [P]. Areas of interest should be marked with an arrow. For EEGs please indicate the gain, 
timescale, and lead position.  
Graphs should be as simple as possible, not three-dimensional, and not framed. Shading should be white, 
black, or strong hatching, not grey. No background lines should be used (except for bars and axes).  
Colour If colour printing of figures is essential for their comprehension; please indicate this in the covering 
letter. There is normally a charge to the author for printing in colour. It is possible to publish a figure in black 
and white in the print version of the issue but in colour in the online version at no extra charge. Please refer 
to the Colour Work Agreement (CWA) form for more information.  
Figures should be numbered in order in the text. A caption must be supplied for each figure. The caption 
should not repeat what is written in the text material and should follow the Journal style (please refer to 
recent issues for examples). All captions should be placed in a list at the end of the main document. Please 
remember to supply captions for figures that will be published electronically. The caption must describe all 
labels in a figure. For images, the caption should include the type of image, its plane, whether or not contrast 
material was used, the pulse sequence information for MR images and the features to be observed by the 
reader. However, full details of the MR sequences should be described in the methods section, not in the 
caption.  
j) Statistical reporting  
The Editors advise reading “Statistical recommendations for papers submitted to Developmental Medicine & 
Child Neurology” (Rigby AS, Dev Med Child Neurol 2010; 52: 293–298) for guidelines on appropriate use 
and reporting of statistical analyses.  
k) Supporting information (supplementary material)  
DMCN publishes online supporting information (including audio and video files, data sets, additional images, 
and large appendices) that cannot be included in the print version of an article. This material should be 
relevant to and supportive of the parent article. For guidelines see 
authorservices.wiley.com/bauthor/suppmat.asp. Authors are encouraged to submit video material to 
support their papers (e.g. to demonstrate techniques or methods, or to demonstrate a randomised controlled 
trial protocol). l) Author Podcasts and Author Videos  
Authors are encouraged to submit a short (two minute) podcast or video highlighting the key features of their 
article, outlining what is novel in their paper, to encourage readers to access the content.  
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1. The recording must be continuous and of sufficient quality for us to publish online i.e. no shaking, blurring 
or interference.  
2. The resolution should be 1280 x 720 (16 x 9 HD) or 640 x 480 (4:3 SD), if possible.  
3. The recording should last no longer than two minutes.  
4. The file must be less than 2GB in size.  
5. The file must be saved in MPEG, MP3 or MP4 format.  
Here are some tips to assist your recording:  
1. Choose a neutral, flat, still background with good light and without background noise.  
2. Make sure you are central in the view finder/screen on the camera and that you are sitting an appropriate 
distance away so that your upper body fills the screen.  
3. Please dress formally, remain relatively still throughout the recording and smile.  
4. Follow the script below.  
5. Speak slowly, and breathe normally when you reach a natural pausing place.  
6. If possible, use a tripod, or ensure that the camera/recording device is placed on a flat surface to avoid 
shaking.  
7. Ask a colleague to start and stop the recording.  
Your script should follow this format:  
1. “Our/my paper in DMCN is [a study of XXXX or a review of XXXXX]”  
2. “What’s already known about this topic is [xxxxx]”  
3. “What’s new in our/my article is [xxxx]”  
Please be aware that the content of the video should not display overt product advertising. In addition to the 
video file, please can you send an accompanying still portrait of yourself/ yourselves. The picture should be a 
head shot and can be taken using a digital camera or mobile phone. This should be saved as a JPEG or 
TIFF file. Please send the video file along with your portrait and an Online Video Broadcast Release Form, 
by email to DMCN Journal dmcn@editorialoffice.co.uk together with details of the paper to which it refers.  
4. Selection and publication 
a) Editorial review  
Submissions are normally sent to at least two independent referees. Case reports and reviews are assessed 
by the Editors and one or more independent referees. During the submission process, authors have the 
opportunity to, and are encouraged to, suggest three suitable independent referees (with their contact 
details) but the choice of referee rests with the Editors. Most papers also undergo statistical review before 
acceptance.  
Editors and editorial board members are not involved in editorial processes or decisions about their own 
work.  
Reviewers are asked to disclose potential conflicts of interest when they are invited to review a paper and 
when they submit their review.  
Papers thought to have immediate, clinically important consequences may be considered for fast-track 
publication. The decision to prioritize remains with the Editors.  
b) After acceptance  
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The Editors reserve the right to determine whether accepted papers will be published in the online version of 
an issue (‘E-Papers’) or in both the print and the online version. E-Papers are listed in the table of contents 
of the issue in which they are published, and their abstracts and citation information appear in the print issue.  
After acceptance, authors will be able to track the progress of their article through production to publication 
by registering for Author Services with Wiley Blackwell. Authors will be sent information about how to register 
for Author Services once their article has been accepted.  
When an accepted paper has been copy-edited, has been approved by the authors, and is ready for 
publication, it will normally be posted online in the journal’s ‘EarlyView’ section before allocation to an issue. 
EarlyView articles are in their final form and are fully published and citable.  
Authors receive a free PDF of the paper soon after publication. Reprints may be ordered when returning 
proofs. Please send no payment: an invoice will be sent shortly after you receive the reprints.  
c) After publication  
If errors affecting the interpretation of data or information are discovered after publication, an erratum will be 
published in the next available issue of the journal and published online.  
5.Style points 
Jargon Avoid it strenuously. The journal aims to communicate across disciplines, and many of its readers do 
not have English as their first language, so plain language is always preferred. The Editors may clarify and 
shorten manuscripts accepted for publication as necessary.  
Abbreviations These should be kept to a minimum and restricted to those that are generally recognised. 
They must be spelled out in full on first usage in text and again in figure captions and table footnotes. They 
should be avoided in titles, headings and subheadings.  
Participant details Give mean (SD) age in years and months (not decimal years) and sex (n, not %). Ensure 
this information is included in the abstract. In the text, indicate where study and comparison groups are from 
and how participants were selected.  
Measurements Use SI units, except for blood pressure (mmHg); convert imperial units to metric. Do not use 
percentages for sample sizes below 50; use the symbol ‘%’ in tables. Show standard deviations as (SD), not 
±. Abbreviate probability with a lower case italicized p.  
Numbers In general, use numerals, but spell out numbers at the beginning of sentences. Spell out numbers 
‘one’ to ‘nine’ if they refer to nouns that are not units of measurement, e.g. ‘The results from four children 
confirm the findings’. For ages and time periods, use years, months, weeks and days, not decimals (e.g. 5 
years 3 months, not 5.25 years).  
Equipment and drugs: Include (in parentheses) the name of the manufacturer, the city, and country of 
production. 
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APPENDIX B 
Study protocol as accepted by HREC 11 December 2014 
The outcomes of children with cerebral palsy and upper airways obstruction at Red Cross War Memorial 
Children’s Hospital 
Background and significance 
Cerebral palsy (CP) has been defined as a group of disorders of the development of movement and posture, 
causing activity limitation that is attributed to non-progressive disturbances that occurred in the developing 
foetal or infant brain. The motor disorders are often accompanied by disturbances of sensation, perception, 
cognition, communication, and behaviour; by epilepsy, and by secondary   musculoskeletal problems. (1) It is 
the most common cause of physical disability in children across the world with prevalence in developed 
countries of 1-2/1000. (23)
, 
(24,25) 
 Limited information is available regarding the epidemiology of cerebral palsy in developing countries. A 
review of intellectual disability in a rural district in the Northern Province published in 2002 reported the 
presence of cerebral palsy in 8.4% of their cohort.(26) Given the burden of disease from infectious diseases 
compared to developed countries and the difference in quality of perinatal care available in developing 
countries, the prevalence of cerebral palsy in the public sector in South Africa can be expected to be higher 
than the previously quoted figures. (27-30)  
Respiratory complications are significant contributors to morbidity and mortality in children with cerebral 
palsy and other developmental disabilities. Children with cerebral palsy are at increased risk of obstructive 
sleep apnoea and upper airways obstruction.(4)(5,6)(3) Mid-facial and gastro intestinal abnormalities as well 
as the underlying low neuromuscular tone of the upper airway predispose children with cerebral palsy to 
upper airway compromise.(3)(7) Contributors to upper airways obstruction during sleep in children with 
cerebral palsy are tonsillar and adenoidal hypertrophy, subglottic stenosis, laryngomalacia, tracheomalacia, 
and obesity.(4) 
The symptoms of upper airways obstruction include snoring, noisy breathing, obstructive sleep apnoea and 
awake airway obstruction and are thought to be underreported by parents.(8) Children may also present with 
complications of chronic upper airways obstruction including pulmonary hypertension and cardiac failure.(7) 
 Upper airway obstruction may be exacerbated during upper and lower respiratory infections and may 
require admission to intensive care unit and result in long term respiratory insufficiency and mortality.(7)(17) 
Chronic upper airways obstruction is an important contributor to poor quality of life in both neurotypical as 
well as children with developmental disabilities like CP.(6) 
The management of upper airways obstruction in children with cerebral palsy is complex due to the 
multifactorial nature of the aetiology and there are no clear guidelines for this important clinical problem.  
Adenotonsillectomy is generally recommended as an appropriate first intervention. 
(14)
 When severe airways 
obstruction persists after interventions like adenoidectomy and tonsillectomy, more invasive procedures have 
been attempted for example uvulopalatopharyngoplasty, maxillofacial procedures as well as tracheostomy 
for definitive airway management. 
(17, 18, 19)
 
Non-invasive interventions in the form of continuous nasal positive pressure or home oxygen have also been 
utilized to administer respiratory support where surgical intervention could not take place. 
(14, 19)
 
There is a paucity of data to guide current best practice in the management of children with cerebral palsy 
and severe upper airways obstruction.  The available publications all present reviews of practices in first 
world settings and report mainly on small groups, often mixed with other disabilities. Many are retrospective 
in nature and do not report long term outcomes or indicators of quality of life of children post intervention. 
This research aims to describe the investigation, management and outcomes of children who were admitted 
to a tertiary setting in Cape Town with cerebral palsy and upper airways obstruction.  The results from this 
study may inform future practice at our institution as well as suggest possible recommendations for the 
management of airways obstruction in resource limited settings. 
Research question: 
What are the outcomes of children with cerebral palsy who were admitted to a tertiary hospital in Cape Town 
with upper airways obstruction? 
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Objectives:   
1. To describe the investigation, management and outcomes of children admitted over a 5 year period 
with upper airways obstruction and cerebral palsy. 
2. To compare the outcomes of children admitted with upper airways obstruction based on the nature 
and severity of the motor disorder of cerebral palsy.  
Aims:   
1. To describe the prevalence and severity of upper airways obstruction in children with cerebral palsy 
admitted over a 5 year period.  
2. To document all investigations performed during hospital admission to evaluate the nature and 
severity of upper airways obstruction. 
3. To document all interventions performed for management of upper airways obstruction in children 
with cerebral palsy.( surgical and non-surgical) 
4. To describe the cohort of children admitted with upper airways obstruction through classification of 
nature and severity of motor disorder (GMFCS scale) and reporting any comorbid conditions 
associated with cerebral palsy. 
5. To compare outcomes of children with upper airways obstruction based on underlying nature and 
severity of motor disorder. 
Research design and methods: 
This will be a descriptive study. A cross sectional retrospective folder review of all children admitted to Red 
Cross War Memorial Hospital with cerebral palsy during the study period will be performed.  
Study population and sampling: 
Selection criteria: 
1.  All children with a diagnosis of cerebral palsy between the ages of 2 – 18 years who were admitted 
to any ward at Red Cross War Memorial Children’s Hospital and documented to have a diagnosis of 
upper airways obstruction between 1 January 2009 and 31 December 2013 will be included in the 
study. 
Exclusion criteria: 
1. Children known with craniofacial disorders including craniosynostosis/ cleft palate will be excluded. 
2. Children who are known with neurodegenerative/ neurometabolic disorders which might contribute to 
progressive airways obstruction will also be excluded. 
A retrospective folder review will be conducted of all children with a diagnosis of cerebral palsy who were 
admitted between 1 January 2009 and 31 December 2014. Demographic and clinical information will be 
collected including the aetiology of cerebral palsy, classification of cerebral palsy, as well as the 
presentation, investigation and management of upper airways obstruction and recorded on a predefined data 
collection form.  Outcome information collected will include one year mortality, number of readmissions in 
subsequent year, as well as duration of hospital admission. 
 See Appendix 1 
Ethical considerations 
Ethical approval will be obtained from UCT HREC prior to commencement of any study activities.  
Informed consent 
Permission will be sought from UCT health ethics review committee as well as the Red Cross War Memorial 
Children’s Hospital to confirm that signed consent forms may be waivered for this study. As this study 
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involves no patient contact and no risk to patient, informed consent will not be obtained from the parent or 
legal guardian. 
Data management 
The principal investigator will check the completed data collection forms for errors and completeness. An 
information database will be set up in EPIDATA by the principal investigator which will be kept on a 
password protected computer. Information will be entered into this electronic database by a research 
assistant. 
Patient confidentiality 
Patient confidentiality will be strictly maintained. Study documentation will be securely stored in a locked 
cabinet in the principal investigator office.  
Data analysis 
Data will be exported from EPIDATA into STATA 13 after it has been cleaned and checked by the principal 
investigator. Statistical analysis will be performed using the STATA program using continuous and 
categorical variables.  A p value of < 0.05 will be considered significant. 
Categorical variables will be reported as percentages and relative percentages with confidence intervals and 
displayed in frequency tables or bar charts. Numerical variables which are normally distributed will be 
analysed and reported using the summary statistics: mean, standard deviation and range. Numerical 
variables which are not normally distributed will be analysed and the median with interquartile range will be 
reported. 
The main outcomes (one year mortality, number of readmissions in subsequent year, as well as duration of 
hospital admission) will be reported as relative percentages with confidence intervals.  
Comparison between groups will be performed by using the X
2 
statistic for binary outcomes and the Kruskal 
Wallis test for numerical outcomes which are not normally distributed. 
Data dissemination plan: 
Publication will be sought in a peer review journal: Developmental Medicine and Child Neurology 
Presentation at national (SAPA 2016) and international conferences (American Academy of Cerebral Palsy 
meeting 2015) 
Presentation to Red Cross War Memorial Hospital as well as Tygerberg children’s Hospital at annual 
research day meetings in 2015. 
Budget & budget justification 
TIME PERIOD ITEM COST 
1 DECEMBER 2014-30 
NOVEMBER 2015 
PERSONNEL R10000 
 CONSUMABLES R500 
October 2015 RESEARCH TRAVEL R10000 
 SPECIALIZED  ITEMS R2500 
   
   
TOTAL  R23000 
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BUDGET JUSTIFICATION: 
Research assistant: 
A research assistant will be used to enter data collection forms into the study database once a week for 5 
hours for a period of 4 months. Assistance with data entry is essential as the principal investigator is a full 
time employee of a busy academic hospital and will not be able to complete both folder reviews as well as 
data entry within the project timeline. 
Consumables: paper for printing of data collection forms and additional paperwork will be purchased at an 
estimated cost of R500. 
Equipment: 
Office computer, printer, furniture and copier will be utilized from the existing infrastructure at Red Cross War 
Memorial Hospital. 
Research travel:  an abstract will be submitted for presentation at the American academy of cerebral palsy 
and developmental medicine. The conference registration fee as well as visa costs are included in the 
budget. Additional funding will be sought for transport and accommodation costs.  
Funding application will be made to the University of Cape Town for a departmental research grant as well 
as conference funding from University of Stellenbosch to cover the cost of budget items. 
Limitations: 
The study will be limited by its retrospective design which is susceptible to bias and confounders.  It may not 
be possible to obtain all the relevant information from the folders, folders may be lost or missing which will 
result in missing data and affect the final results. 
The results of the study may not be generalizable to the all children with cerebral palsy. 
However as the research question involves a vulnerable population and a life threatening condition, the 
study design is considered the most appropriate way to address this issue. 
References: 
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APPENDIX C 
STUDY QUESTIONNAIRE   as approved by HREC December 2014 
STUDY NUMBER    FOLDER NUMBER  
DATE OF BIRTH SEX  
CEREBRAL PALSY  
AETIOLOGY OF CP: TICK  
ANTENATAL  PERINATAL  POSTNATAL  
CLASSIFICATION OF CP TICK  
BILATERAL  UNILATERAL  
TONE ABNORMALITY: TICK  
SPASTIC  DYSTONIC  MIXED   ATAXIC  HYPOTONIA  
GMFCS: TICK APPROPRIATE LEVEL  
I  II  III  IV  V  
COIMPAIRMENTS:  
EPILEPSY Y/N  VISUAL IMPAIRMENT Y/N  HEARING IMPAIRMENT Y/N  
MUSCULOSKELETAL IMPAIRMENT Y/N GASTROINTESTINAL COMPLICATIONS Y/N  
PRESENCE OF GASTROSTOMY Y/N  
ADMISSION DIAGNOSIS UPPER AIRWAYS OBSTRUCTION: Y/N  
AGE ON ADMISSION IN MONTHS: ______  
SYMPTOMS OF UAO ON ADMISSION:  
SNORE: Y/N STRIDOR: Y/N NOISY BREATHING OTHER: Y/N  
SLEEP APNOEA: Y/N AWAKE APNOEA: Y/N  
URTI: Y/N      LRTI: Y/N  
WEIGHT NUTRITIONAL CLASSIFICATATION  
INVESTIGATIONS:  
CXR: Y/N PNEUMONIA Y/N RVH: Y/N  
ECG: Y/N ABN: Y/N RVH: Y/N  
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PNS XRAY: Y/N ADENOIDAL HYPERTROPHY ON PNS: Y/N  
ABG: Y/N RESULT:  
SLEEP SATURATIONS: Y/N  RESULT:____________________________________  
FORMAL OVERNIGHT POLYSOMNOGRAPGY: Y/N  
RESULT: ___________________________________________________________  
NASAL ENDOSCOPY: Y/N  RESULT____________________________  
ENT CONSULT: Y/N  PULMONOLOGY CONSULT: Y/N  CARDIOLOGY CONSULT:Y/N  
CP DOCTOR CONSULT: Y/N  MDT DISCUSSION: Y/N  
FINAL ASSESSMENT OF AETIOLOGY OF UAO: ______________________________________  
MANAGEMENT: PLEASE TICK  
NCPAP: Y/N  DURATION:  CIPP TUBE: Y/N  DURATION:  
IPPV: Y/N  DURATION  ICU ADMISSION: Y/N  DURATION OF ICU ADMISSION: _____ DAYS  
MANAGEMENT: TONSILLECTOMY: Y/N  ADENOIDECTOMY: Y/N  
TONSILLECTOMY AND ADENOIDECTOMY: Y/N  SUPPORTIVE MANAGEMENT ONLY:  
TRACHEOSTOMY:Y/N OTHER :  
DISCHARGE SATS__ DISCHARGE SLEEP SATS___  
MEDICATION:  
OUTCOMES:  
DURATION OF HOSPITAL ADMISSION: ___________DAYS  
NUMBER OF READMISSIONS TO HOSPITAL FOR UAO COMPLAINTS: READMISSIONS OTHER  
NUMBER OF READMISSIONS TO ICU FOR UAO COMPLAINTS:  
DEATH: Y/N  
DEATH WITHIN ONE YEAR  
DEATH AFTER ONE YEAR BUT IN STUDY PERIOD  
CAUSE OF DEATH  
NOSOCOMIAL INFECTIONS: _____________________________  
WEIGHT AT 1 YEAR  
NUTRITIONAL STATUS 
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APPENDIX D 
ETHICS  
Permission was obtained from the University of Cape Town HREC to proceed without individual consent as 
the study was retrospective in nature and did not pose any risks to participants. In addition permission was 
obtained from the hospital management to proceed without individual consent. Confidentiality was strictly 
maintained. 
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APPENDIX F 
TURNITIN REPORT  
RESPONSE TO TURNITIN REPORT 
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